Ovidiu Trifan - Publications

Affiliations: 
Onyx Pharmaceuticals 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Payner T, Leaver HA, Knapp B, Whittle IR, Trifan OC, Miller S, Rizzo MT. Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase A. Molecular Cancer Therapeutics. 5: 1817-26. PMID 16891468 DOI: 10.1158/1535-7163.MCT-05-0548  0.327
2005 Narko K, Zweifel B, Trifan O, Ristimäki A, Lane TF, Hla T. COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice. Prostaglandins & Other Lipid Mediators. 76: 86-94. PMID 15967164 DOI: 10.1016/J.Prostaglandins.2005.01.002  0.633
2004 Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 101: 591-6. PMID 14688410 DOI: 10.1073/Pnas.2535911100  0.676
2003 Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. Journal of Cellular and Molecular Medicine. 7: 207-22. PMID 14594546 DOI: 10.1111/J.1582-4934.2003.Tb00222.X  0.558
2003 Davis TW, Hunter N, Trifan OC, Milas L, Masferrer JL. COX-2 inhibitors as radiosensitizing agents for cancer therapy. American Journal of Clinical Oncology. 26: S58-61. PMID 12902857 DOI: 10.1097/01.COC.0000074158.59269.9F  0.327
2003 Chu J, Lloyd FL, Trifan OC, Knapp B, Rizzo MT. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Molecular Cancer Therapeutics. 2: 1-7. PMID 12533667  0.337
2002 Trifan OC, Durham WF, Salazar VS, Horton J, Levine BD, Zweifel BS, Davis TW, Masferrer JL. Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. Cancer Research. 62: 5778-84. PMID 12384538  0.344
2001 Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. The Journal of Biological Chemistry. 276: 18563-9. PMID 11278747 DOI: 10.1074/Jbc.M010787200  0.681
2000 Jang BC, Sanchez T, Schaefers HJ, Trifan OC, Liu CH, Creminon C, Huang CK, Hla T. Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. The Journal of Biological Chemistry. 275: 39507-15. PMID 10993880 DOI: 10.1074/Jbc.M003224200  0.624
1999 Trifan OC, Smith RM, Thompson BD, Hla T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. The Journal of Biological Chemistry. 274: 34141-7. PMID 10567385 DOI: 10.1074/Jbc.274.48.34141  0.528
1999 Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and -2 isoenzymes. The International Journal of Biochemistry & Cell Biology. 31: 551-7. PMID 10399316 DOI: 10.1016/S1357-2725(98)00152-6  0.651
1998 Trifan OG, Bishop-Bailey D, Hla T. Inducible cyclooxygenase-2 overexpression using the ecdysone-inducible gene expression system Faseb Journal. 12: A1384.  0.629
Show low-probability matches.